Table 4.

Univariable logistic regression analysis for the probability of developing AKI following TAVI.

		n = 210
		OR	95% CI	p Value
eGFR reduction by 1 mL/min/1.73 m2		1.036	1.017–1.056	<0.001
eGFR <45 mL/min/1.73 m2		4.14	1.93–8.9	0.003
Hemoglobin reduction by 1 g/dL		1.33	1.06–1.66	0.013
STS score for mortality		1.0387	1.009–1.069	0.009
Diabetes Mellitus		1.4	0.694–2.835	0.345
Hypertension		1.18	0.381–3.66	0.772
Body mass index		0.974	0.91–1.04	0.458
Gender		0.955	0.471–1.936	0.9
Age		1.041	0.992–1.094	0.1
Left ventricle ejection fraction		0.998	0.965–1.032	0.917
NYHA functional class		1.252	0.474–3.303	0.65
Coronary artery disease		1.836	0.881–3.824	0.105
Peripheral arterial disease		1.818	0.704–4.695	0.217
Within 30 Days	CM volume	1.001	0.997–1.003	0.971
	CM/CrCl	1.182	1.058–1.321	0.004
	(CM × Scr)/BMI	1.062	1.014–1.113	0.011
	(CM × Scr)/BW	1.169	1.036–1.139	0.012
	Mehran Score	1.109	1.03–1.195	0.006
	CR4EATME3AD3 score	1.137	1.035–1.249	0.007
Within 7 Days	Volume of CM	1.009	0.998–1.004	0.538
	CM/CrCl	1.216	1.073–1.379	0.002
	(CM × Scr)/BMI	1.069	1.012–1.128	0.017
	(CM × Scr)/BW	1.19	1.036–1.367	0.014
	Mehran Score	1.118	1.037–1.205	0.004
	CR4EATME3AD3 score	1.146	1.041–1.262	0.005
TAVI	Volume of CM	1.002	0.998–1.007	0.295
	CM/CrCl	1.237	1.069–1.43	0.004
	(CM × SCr)/BMI	1.092	1.021–1.167	<0.001
	(CM × SCr)/BW	1.275	1.069–1.521	0.007
	Mehran Score	1.102	1.013–1.2	0.025
	CR4EATME3AD3 score	1.147	1.043–1.261	0.005
Modified Mehran score ^		1.11	1.028–1.199	0.008
Modified CR4EATME3AD3 score ^		1.146	1.041–1.261	0.005

AKI—acute kidney injury; TAVI—transcatheter aortic valve implantation; eGFR—estimated glomerular filtration rate; NYHA—New-York Heart Association; PAD—peripheral arterial disease, CVD—cardiovascular disease; CM—contrast media; SCr—serum creatinine; CrCl—creatinine clearance; BMI—body mass index, BW—body weight. ^ Calculated without contrast media module.